Category: Genetic Counseling

• Implementing digital systems to facilitate genetic testing for hereditary cancer syndromes: An observational study of four clinical workflows.
• Wang C, Lu H, Bowen DJ, Xuan Z.
• Genet Med. 2023 Feb 10:S1098-3600(23)00815-8. doi: 10.1016/j.gim.2023.100802. Epub ahead of print.

• Source abstract

• Proactive breast cancer risk assessment in primary care: a review based on the principles of screening.
• Usher-Smith JA, Hindmarch S, French DP, Tischkowitz M, Moorthie S, Walter FM, Dennison RA, Stutzin Donoso F, Archer S, Taylor L, Emery J, Morris S, Easton DF, Antoniou AC.
• Br J Cancer. 2023 Feb 3:1–11. doi: 10.1038/s41416-023-02145-w. Epub ahead of print.

• PMID: 36737659
• PubMed abstract

• Review
• Free PMC article
• Free Full Text

• Women's Metaphors About BRCA Gene Testing and How They Can Inform Health Communication Theory and Practice.
• Martin SC, Scott AM, Stone AM.
• Health Commun. 2023 Feb 12:1-13. doi: 10.1080/10410236.2023.2178051. Epub ahead of print.

• PMID: 36775863
• PubMed abstract
• Source abstract

• Coping Self-Efficacy and Its Relationship with Psychological Morbidity after Genetic Test Result Disclosure: Results from Cancer-Unaffected BRCA1/2 Mutation Carriers.
• Isselhard A, Lautz Z, Töpper M, Rhiem K, Schmutzler R, Vitinius F, Fischer H, Berger-Höger B, Steckelberg A, Beifus K, Köberlein-Neu J, Stock S.
• Int J Environ Res Public Health. 2023 Jan 17;20(3):1684. doi: 10.3390/ijerph20031684.

• PMID: 36767056
• PubMed abstract

• Free Full Text

• Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in BRCA2.
• Mayoral I, Almeida Santiago A, Sánchez-Zapardiel JM, Hidalgo Calero B, de la Hoya M, Gómez-Sanz A, de Miguel Reyes M, Robles L.
• Genes (Basel). 2023 Feb 15;14(2):502. doi: 10.3390/genes14020502.

• Free Full Text

• Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
• Kinney AY, Walters ST, Lin Y, Lu SE, Kim A, Ani J, Heidt E, Le Compte CJG, O'Malley D, Stroup A, Paddock LE, Grumet S, Boyce TW, Toppmeyer DL, McDougall JA.
• J Clin Oncol. 2023 Feb 14:JCO2200751. doi: 10.1200/JCO.22.00751. Epub ahead of print.

• PMID: 36787512
• PubMed abstract

• Free Full Text

Related:

•• Identifier: NCT03326713: Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project (GRACE). (ClinicalTrials.gov . Accessed 2023 Feb 14.)

• Mainstream genetic testing for high-grade ovarian, tubal and peritoneal cancers: A tertiary referral centre experience.
• Srinivasa S, Bowman M, Titterton L, Harnett P, Brand A, Kirk J, Ragunathan A.
• Aust N Z J Obstet Gynaecol. 2023 Feb 13. doi: 10.1111/ajo.13650. Epub ahead of print.

• PMID: 36785489
• PubMed abstract
• Source abstract

• Role of psychological background in cancer susceptibility genetic testing distress: It is not only about a positive result.
• López-Fernández A, Villacampa G, Salinas M, Grau E, Darder E, Carrasco E, Solanes A, Velasco A, Torres M, Munté E, Iglesias S, Torres-Esquius S, Tuset N, Diez O, Lázaro C, Brunet J, Corbella S, Balmaña J.
• J Genet Couns. 2023 Feb 7. doi: 10.1002/jgc4.1687. Epub ahead of print.

• PMID: 36748747
• PubMed abstract
• Source abstract

• Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels.
• Chang EY, Solomon I, Culver JO, Gorman N, Comeaux JG, Lerman C, Quinn EA, Ekstein T.
• J Genet Couns. 2023 Feb 6. doi: 10.1002/jgc4.1680. Epub ahead of print.

• PMID: 36747331
• PubMed abstract
• Source abstract

• Free Full Text

• Socioeconomic Factors Are Associated With Disparities in Germline Testing in Pancreatic Cancer.
• King D, Scott R.
• OncLive. 2023 Feb 5.

• Conference report, Interview
• Free Full Text

• Germline Testing in Prostate Cancer: Implementation and Disparities of Care.
• Brown LC, Armstrong AJ.
• JCO Oncol Pract. 2023 Jan 31:OP2200804. doi: 10.1200/OP.22.00804. Epub ahead of print.

• PMID: 36720077
• PubMed abstract

• Commentary
• Free Full Text

• Development of an EHR-integrated electronic tool for the identification of individuals at-risk for an inherited cancer syndrome. [2022 CGA-IGC Annual Meeting: The collaborative group of the Americas on Inherited Gastrointestinal Cancer November 11–13, 2022.]
• Singh V, Rafter T, Sharbatji M, Brierley K, Healy C, Liu J, Brown Q, Xicola R, Kashyap N, Llor X.
• Fam Cancer. [O-06: Research Categories» Lynch syndrome.] 2023 Jan 23. doi: 10.1007/s10689-022-00324-x. Epub ahead of print.

• Source abstract

• Conference abstract

• Decreased time from diagnosis to referral of PDAC patients: a quality improvement effort. [2022 CGA-IGC Annual Meeting: The collaborative group of the Americas on Inherited Gastrointestinal Cancer November 11–13, 2022.]
• Cohen SA, Doran W, Harshbarger C, Nixon DM, Lichtenberg E, Cantafio A.
• Fam Cancer. [P-24: Research Categories» Delivery of Care and Alternative Models.] 2023 Jan 23. doi: 10.1007/s10689-022-00324-x. Epub ahead of print.

• Source abstract

• Conference abstract

• Pairing tumor testing with germline sequencing increases the number of pathogenic germline variants identified. [2022 CGA-IGC Annual Meeting: The collaborative group of the Americas on Inherited Gastrointestinal Cancer November 11–13, 2022.]
• Nefeli Dimopoulos C, Brierly K, Gibson J, Walther Z, Llor X.
• Fam Cancer. [P-32: Research Categories» Gastric cancer-related syndromes.] 2023 Jan 23. doi: 10.1007/s10689-022-00324-x. Epub ahead of print.

• Source abstract

• Conference abstract

• Disparities in the uptake of cascade genetic testing among family members of mutation-positive lynch and HBOC syndrome patients. [2022 CGA-IGC Annual Meeting: The collaborative group of the Americas on Inherited Gastrointestinal Cancer November 11–13, 2022.]
• Namey E, Dudley B, Horton C, Carraway C, Zhou J, Hatton W, Komala T, Milliard C, Namey T, Karloski E, Brand R.
• Fam Cancer. [O-05: Research Categories» Lynch syndrome.] 2023 Jan 23. doi: 10.1007/s10689-022-00324-x. Epub ahead of print.

• Source abstract

• Conference abstract

• Actionable pathogenic germline variants discovered by panel-based hereditary cancer testing in families with previously identified pathogenic variants. [2022 CGA-IGC Annual Meeting: The collaborative group of the Americas on Inherited Gastrointestinal Cancer November 11–13, 2022.]
• Neumann C, Mcsweeny M, Rainey K, Campbell H, Nguyen C, Hall M.
• Fam Cancer. [P-13: Research Categories » Counseling, Behavioral Health, Psychosocial, and Survivorship.] 2023 Jan 23. doi: 10.1007/s10689-022-00324-x. Epub ahead of print.

• Source abstract

• Conference abstract

• Genetic Testing Challenges in Oncology: Patient With Pending Bill Has BRCA1 Result Withheld.
• Ray T.
• Precision Oncology News. 2023 Jan 23.

• Case report
• Free Full Text

• Outcomes of Universal Point-of-Care Genetic Testing in Diverse Patients With Pancreatic Ductal Adenocarcinoma.
• Drogan CM, Kindler HL, Gao G, Kupfer SS.
• JCO Precis Oncol. 2023 Jan;7:e2200196. doi: 10.1200/PO.22.00196.

• PMID: 36689696
• PubMed abstract
• Source abstract

• Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.
• Gómez-Trillos S, Graves KD, Fiallos K, Schwartz MD, Peshkin BN, Hamilton H, Sheppard VB, Vadaparampil ST, Campos C, Cupertino AP, Alzamora MC, Lynce F, Hurtado-de-Mendoza A.
• Transl Behav Med. 2023 Jan 24:ibac106. doi: 10.1093/tbm/ibac106. Epub ahead of print.

• PMID: 36694918
• PubMed abstract
• Source abstract